Skip to main content

Accendra Health, Inc.

corporate_fare Company Profile

Accendra Health, Inc.

ACH·NYSE·Trade & Services·CIK 0000075252

General Accendra Health, Inc. is a nationwide provider of products, technology, and services that supports health beyond the hospital. The company connects patients, providers, and insurers, delivering solutions to promote better health outcomes and improve quality of life for people with chronic, complex, and acute health conditions. Its trusted brands, Apria and Byram Healthcare, have nearly 90 years of combined experience. The company is headquartered in Richmond, Virginia. On October 7, 2025, the company entered into an Equity Purchase Agreement to sell its Products & Healthcare Services (P&HS) business for an aggregate of $375 million in cash, subject to certain adjustments. This sale was completed on December 31, 2025. The company has retained a 5% equity interest in the P&HS business. General Accendra Health provides delivery of products, including disposable medical supplies sold directly to patients and home health agencies. It is a leading provider of integrated home healthcare equipment and related services in the U.S. The company offers a comprehensive range of products and services for in-home care and delivery across diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure (CPAP) and bi-level positive airway pressure devices, and patient support services).

Accendra Health, Inc. (NYSE:ACH) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 23 items for ACH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-30, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for ACH spans 8-K, DEF 14A, PRE 14A, 144.

Recent high-impact activity:

  • Accendra Health Hit With Second NYSE Deficiency Notice — Market Cap and Equity Below $50M
  • Accendra Health Hit With Second NYSE Deficiency Notice, This Time on Market Cap and Equity
  • Accendra Sets Dec 1 Vote on 1-for-20 to 1-for-30 Reverse Split to Cure NYSE Price Deficit
  • Accendra Seeks 1-for-20 to 1-for-30 Reverse Split to Cure NYSE Delisting Notice
  • NYSE Flags Accendra Health for Sub-$1 Share Price; Reverse Split on Table

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.76B
Net Income
-$1.1B
Diluted EPS
-$14.31
Gross Profit
$1.29B
Operating Income
$27.46M
Cash & Equivalents
$281.99M
Total Debt
$250M
Debt / Equity
-0.54×
Net Margin
-39.8%
Shares Outstanding
76.39M sh
Source: 10-K · filed 2026-02-20 · accession 0001104659-26-018169

Short Interest & Short Volume

4.91 days to cover

FINRA reported short interest of 9,105,129 shares in ACH as of the October 15, 2026 settlement, a 8.1% increase from the prior period — about 4.9 days to cover at its recent average daily volume. On October 30, 2026, 32.6% of ACH volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)9,105,129 shares as of October 15, 2026
Change vs prior period▲ 8.1%
Days to cover4.91 at avg daily volume of 1,854,497
Daily short volume (FINRA facilities)32.6% of 769,037 shares on October 30, 2026
5-day average short volume51.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for ACH, detected from its recent SEC filings.

1 shelf registration

Shelf Registration Filed · No Immediate Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with A →
$0.2581 +1.53% today
52-week range · as of 2026-10-30 $0.191 – $5.24
Market cap
$19.56M
Volume
1.6M (0.8× avg)
3-mo avg 2M
Live data · 2026-11-02 02:42 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ACH - Latest Insights

ACH
Oct 30, 2026, 4:50 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.250
Real-time Price: $0.2581 info
Change: +$0.0081 (+3%) info
Market Cap: $19.565M info
ACH
Oct 30, 2026, 4:45 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.2816
Real-time Price: $0.2581 info
Change: -$0.0235 (-8%) info
Market Cap: $19.565M info
ACH
Oct 29, 2026, 4:15 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.233
Real-time Price: $0.2581 info
Change: +$0.0251 (+11%) info
Market Cap: $19.565M info
ACH
Oct 19, 2026, 5:16 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.210
Real-time Price: $0.2581 info
Change: +$0.0481 (+23%) info
Market Cap: $19.565M info
ACH
Oct 09, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
8
Updated Oct 9, 4:12 PM ET — Accendra Health received an NYSE notice on October 6, 2026, for its stock averaging below $1.00 over 30 trading days, and plans to cure, po…
Price at Filing: $0.428
Real-time Price: $0.2581 info
Change: -$0.1699 (-40%) info
Market Cap: $19.565M info
ACH
Sep 17, 2026, 6:35 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.06
Real-time Price: $0.2581 info
Change: -$0.8024 (-76%) info
Market Cap: $19.565M info
ACH
Sep 11, 2026, 4:30 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $1.08
Real-time Price: $0.2581 info
Change: -$0.8219 (-76%) info
Market Cap: $19.565M info
ACH
Aug 10, 2026, 11:15 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.31
Real-time Price: $0.2581 info
Change: -$1.05 (-80%) info
Market Cap: $19.565M info
ACH
Aug 10, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.80
Real-time Price: $0.2581 info
Change: -$2.54 (-91%) info
Market Cap: $19.565M info
ACH
Aug 10, 2026, 6:47 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.70
Real-time Price: $0.2581 info
Change: -$2.44 (-90%) info
Market Cap: $19.565M info
ACH
Aug 10, 2026, 6:36 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.79
Real-time Price: $0.2581 info
Change: -$2.53 (-91%) info
Market Cap: $19.565M info
ACH
Jun 25, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.17
Real-time Price: $0.2581 info
Change: -$2.91 (-92%) info
Market Cap: $19.565M info
ACH
Jun 15, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $3.03
Real-time Price: $0.2581 info
Change: -$2.77 (-91%) info
Market Cap: $19.565M info
ACH
Jun 15, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.03
Real-time Price: $0.2581 info
Change: -$2.77 (-91%) info
Market Cap: $19.565M info
ACH
May 22, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.83
Real-time Price: $0.2581 info
Change: -$2.57 (-91%) info
Market Cap: $19.565M info
ACH
May 11, 2026, 11:59 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.96
Real-time Price: $0.2581 info
Change: -$3.70 (-93%) info
Market Cap: $19.565M info
ACH
May 11, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.84
Real-time Price: $0.2581 info
Change: -$3.58 (-93%) info
Market Cap: $19.565M info
ACH
May 11, 2026, 6:35 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.58
Real-time Price: $0.2581 info
Change: -$3.32 (-93%) info
Market Cap: $19.565M info
ACH
May 11, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $3.58
Real-time Price: $0.2581 info
Change: -$3.32 (-93%) info
Market Cap: $19.565M info
ACH
May 04, 2026, 8:34 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.74
Real-time Price: $0.2581 info
Change: -$3.48 (-93%) info
Market Cap: $19.565M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets